Postmarket Drug Surveillance Programs (FDA)
"Because all possible side effects of a drug can't be anticipated based on preapproval studies involving only several hundred to several thousand patients, FDA maintains a system of postmarketing surveillance and risk assessment programs to identify adverse events that did not appear during the drug approval process. FDA monitors adverse events such as adverse reactions and poisonings."
- data description
- web site
- data download link (data not yet available)
- existing tool(s) - if applicable
Comments (0)
You don't have permission to comment on this page.